LFVCX | VSIIX | LFVCX / VSIIX | |
Total Expense Ratio | 2.03 | 0.06 | 3,383% |
Annual Report Gross Expense Ratio | 2.10 | 0.06 | 3,500% |
Fund Existence | 6 years | 26 years | - |
Gain YTD | -2.999 | 2.903 | -103% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1500 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 91.4M | 55.6B | 0% |
Annual Yield % from dividends | 0.00 | 2.12 | - |
Returns for 1 year | -8.18 | 5.59 | -146% |
Returns for 3 years | 9.52 | 31.09 | 31% |
Returns for 5 years | 43.48 | 89.04 | 49% |
Returns for 10 years | N/A | 102.89 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
HAGIX | 83.44 | 0.75 | +0.91% |
Carillon Eagle Mid Cap Growth I | |||
VYMRX | 16.91 | 0.14 | +0.83% |
Voya Mid Cap Research Enhanced Index C | |||
GLCCX | 21.93 | 0.13 | +0.60% |
Goldman Sachs Large Cap Gr Insghts C | |||
GMXPX | 24.48 | 0.07 | +0.29% |
Goldman Sachs Large Cp Val Insghts P | |||
LHCOX | 18.64 | 0.05 | +0.27% |
Lord Abbett Health Care F3 |